H.C. Stancer

618 total citations
24 papers, 446 citations indexed

About

H.C. Stancer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Spectroscopy. According to data from OpenAlex, H.C. Stancer has authored 24 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 4 papers in Spectroscopy. Recurrent topics in H.C. Stancer's work include Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Analytical Chemistry and Chromatography (2 papers). H.C. Stancer is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Analytical Chemistry and Chromatography (2 papers). H.C. Stancer collaborates with scholars based in Canada, United States and United Kingdom. H.C. Stancer's co-authors include Jerry J. Warsh, C. Ezrin, K. L. Reed, Donald V. Coscina, Damodar D. Godse, Siu Wa Tang, Daiga M. Helmeste, Jo Seggie, Kenneth R. Magee and Bruce Quarrington and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Endocrinology.

In The Last Decade

H.C. Stancer

24 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H.C. Stancer Canada	12	123	107	88	50	45	24	446
V. S. Fang United States	17	230 1.9×	197 1.8×	178 2.0×	61 1.2×	14 0.3×	50	912
Donald W. Ashbrook United States	7	138 1.1×	67 0.6×	69 0.8×	36 0.7×	72 1.6×	9	544
Halina Matsumoto Poland	13	150 1.2×	63 0.6×	73 0.8×	20 0.4×	8 0.2×	25	566
A. Barkai United States	13	159 1.3×	153 1.4×	70 0.8×	8 0.2×	10 0.2×	32	579
Yukio Kawakita Japan	16	188 1.5×	211 2.0×	105 1.2×	17 0.3×	3 0.1×	49	601
E. L. Phelan New Zealand	13	139 1.1×	132 1.2×	39 0.4×	35 0.7×	13 0.3×	28	588
J. L. Elghozi France	10	120 1.0×	117 1.1×	34 0.4×	12 0.2×	12 0.3×	18	585
B. Fyrö Sweden	18	325 2.6×	144 1.3×	374 4.3×	47 0.9×	7 0.2×	35	908
N. Bjørum Denmark	13	46 0.4×	25 0.2×	178 2.0×	13 0.3×	11 0.2×	21	446
Hamed Sadeghipour Iran	14	233 1.9×	125 1.2×	145 1.6×	10 0.2×	7 0.2×	30	644

Countries citing papers authored by H.C. Stancer

Since Specialization

Citations

This map shows the geographic impact of H.C. Stancer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.C. Stancer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.C. Stancer more than expected).

Fields of papers citing papers by H.C. Stancer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.C. Stancer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.C. Stancer. The network helps show where H.C. Stancer may publish in the future.

Co-authorship network of co-authors of H.C. Stancer

This figure shows the co-authorship network connecting the top 25 collaborators of H.C. Stancer. A scholar is included among the top collaborators of H.C. Stancer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.C. Stancer. H.C. Stancer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stancer, H.C., et al.. (1989). Toronto‐Rochester depression study of 116 HLA‐typed kindreds. Genetic Epidemiology. 6(1). 191–194. 2 indexed citations

Weitkamp, L.R. & H.C. Stancer. (1989). Analysis of the Toronto‐Rochester depression study follow‐up data confirms an HLA‐region gene contribution to susceptibility to affective disorder. Genetic Epidemiology. 6(1). 305–310. 10 indexed citations

Stancer, H.C., et al.. (1988). Confirmation of the relationship of HLA (chromosome 6) genes to depression and manic depression II. The Ontario follow‐up and analysis of 117 kindreds. Annals of Human Genetics. 52(4). 279–298. 26 indexed citations

Stancer, H.C., Claire L. Mellor, L.R. Weitkamp, et al.. (1987). The Relationship of HLA to Depression and Manic Depression. I. The Newfoundland Follow-Up. The Canadian Journal of Psychiatry. 32(9). 768–772. 3 indexed citations

Stancer, H.C. & K. L. Reed. (1986). Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant's serum. American Journal of Psychiatry. 143(12). 1597–1600. 47 indexed citations

Tang, Siu Wa, Daiga M. Helmeste, & H.C. Stancer. (1979). Interaction of antidepressants with clonidine on rat brain total 3-methoxy-4-hydroxyphenylglycol. Canadian Journal of Physiology and Pharmacology. 57(4). 435–437. 47 indexed citations

Helmeste, Daiga M., H.C. Stancer, Donald V. Coscina, S. Takahashi, & Jerry J. Warsh. (1979). The contribution of CNS MHPG to plasma MHPG in the rat. Life Sciences. 25(7). 601–605. 8 indexed citations

Tang, Siu Wa, H.C. Stancer, & Jerry J. Warsh. (1978). CNS 3-methoxy-4-hydroxyphenylglycol: Its peripheral assessment by isotopic dilution and theoretical significance. Brain Research Bulletin. 3(6). 669–674. 3 indexed citations

Stancer, H.C., et al.. (1977). Brain and blood indole metabolites after peripheral administration of14C-5-HT in rat. Neurochemical Research. 2(1). 39–50. 18 indexed citations

10.

Warsh, Jerry J., Damodar D. Godse, H.C. Stancer, Peter W. Y. Chan, & Donald V. Coscina. (1977). Brain tryptamine in rats by a new gas chromatography-mass fragmentographic method. Biochemical Medicine. 18(1). 10–20. 26 indexed citations

11.

Warsh, Jerry J. & H.C. Stancer. (1976). Brain and peripheral metabolism of 5-hydroxytryptophan-14C following peripheral decarboxylase inhibition.. Journal of Pharmacology and Experimental Therapeutics. 197(3). 545–555. 24 indexed citations

12.

Warsh, Jerry J., Donald V. Coscina, & H.C. Stancer. (1976). Effect of midbrain raphé lesions or intracisternal 6-hydroxydopamine administration on D,L-5-hydroxytryptophan-14C metabolism after peripheral decarboxylase inhibition. Brain Research Bulletin. 1(3). 273–278. 5 indexed citations

13.

Ezrin, C., et al.. (1973). HYPOTHYROIDISM AND HYPERPARATHYROIDISM ASSOCIATED WITH LITHIUM. The Lancet. 302(7824). 331–332. 71 indexed citations

14.

Coscina, Donald V., Jo Seggie, Damodar D. Godse, & H.C. Stancer. (1973). Induction of rage in rats by central injection of 6-hydroxydopamine. Pharmacology Biochemistry and Behavior. 1(1). 1–6. 39 indexed citations

15.

Sastry, P. S., et al.. (1973). Incorporation of Orthophosphate³²Pi into the Phospholipids of Slices of Gonads, Anterior Pituitary and Liver of Calf. Endocrinology. 92(6). 1786–1789. 1 indexed citations

16.

Sastry, P. S., et al.. (1973). Incorporation of³²P₁. Orthophosphate into Phospholipids of Calf Pineal Slices in the Presence and Absence of Neurotransmitters. Endocrinology. 92(6). 1588–1595. 9 indexed citations

17.

Stancer, H.C., et al.. (1971). LITHIUM CARBONATE AND ŒDEMA. The Lancet. 298(7731). 985–985. 7 indexed citations

18.

Magee, Kenneth R., et al.. (1970). Blindness and menarche. Life Sciences. 9(1). 7–12. 37 indexed citations

19.

Sastry, P. S., et al.. (1969). LIPID COMPOSITION OF HUMAN, BOVINE AND SHEEP PINEAL GLANDS. Journal of Neurochemistry. 16(5). 707–714. 11 indexed citations

20.

Heald, P. J. & H.C. Stancer. (1962). Precursors in the metabolism of phosphoproteins in cerebral tissue. Biochimica et Biophysica Acta. 56. 111–117. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact